Search
for

    Sort by

    Research 151–180 of 1000+

    1. The influence of interferon on healthy and diseased skin Cytokine · 2018 · 32 citations
    2. Immunology of alopecia areata 2020 · 23 citations
    3. Genetic Insights into Acne, Androgenetic Alopecia, and Alopecia Areata: Implications for Mechanisms and Precision Dermatology Cosmetics · 2025
    4. Tertiary Lymphoid Organs at the Center Stage of Skin's Humoral Immunity Immunological Reviews · 2025
    5. Tofacitinib (Selective Janus Kinase Inhibitor 1 and 3): A promising therapy for the treatment of alopecia areata: A case report of six patients International Journal of Trichology · 2018 · 24 citations
    6. A Comprehensive Literature Review of JAK Inhibitors in Treatment of Alopecia Areata Clinical, cosmetic and investigational dermatology · 2021 · 40 citations
    7. Multiomics Analysis of the Response to Ritlecitinib in Alopecia Areata Subtypes and Correlation With Efficacy Allergy · 2025
    8. Review of Promising Off-Label Use of Deucravacitinib International Journal of Molecular Sciences · 2025
    9. Detection of Serum Levels of Interleukins-17, 21, 6 and Tumor Necrosis Factor-α in Patients with Patchy Alopecia Areata and Their Association with Disease Severity Diseases · 2025
    10. Chronic graft versus host disease and skin Journal of the European Academy of Dermatology and Venereology · 2003 · 32 citations
    11. Diabetes mellitus: interdisciplinary medical, surgical and psychological therapeutic approach Journal of Mind and Medical Sciences · 2023 · 12 citations
    12. Targeting the Janus Kinase Family in Autoimmune Skin Diseases Frontiers in Immunology · 2019 · 124 citations
    13. Cytokine Engineering Approaches for Regenerative Medicine Advanced Therapeutics · 2025 · 3 citations
    14. JAK inhibition decreases the autoimmune burden in Down syndrome eLife · 2024 · 18 citations
    15. JAK inhibition decreases the autoimmune burden in Down syndrome eLife · 2024 · 2 citations
    16. The Efficacy and Psychoneuroimmunology Mechanism of Camouflage Combined With Psychotherapy in Vitiligo Treatment Frontiers in Medicine · 2022 · 7 citations
    17. Developing a JAK Inhibitor for Targeted Local Delivery: Ruxolitinib Cream Pharmaceutics · 2021 · 24 citations
    18. Vitiligo—Current Treatment Options and Future Perspectives International Journal of Molecular Sciences · 2026
    19. Pathological sequelae of long-haul COVID Nature Immunology · 2022 · 353 citations
    20. The Human Skin Microbiome in Selected Cutaneous Diseases Frontiers in cellular and infection microbiology · 2022 · 47 citations
    21. SOCS1 and SOCS3 as key checkpoint molecules in the immune responses associated to skin inflammation and malignant transformation Frontiers in Immunology · 2024 · 26 citations
    22. Autoantigen Discovery in the Hair Loss Disorder, Alopecia Areata: Implication of Post-Translational Modifications Frontiers in immunology · 2022 · 11 citations
    23. Efficacy of diphenylcyclopropenone in alopecia areata: a comparison of two treatment regimens Postępy Dermatologii i Alergologii · 2018 · 10 citations
    24. Alopecia Areata: An Updated Review for 2023 Journal of Cutaneous Medicine and Surgery · 2023 · 91 citations
    25. The brain–gut–skin axis in inflammatory and disfiguring skin diseases: mechanistic insights, clinical correlations, and therapeutic strategies Frontiers in Immunology · 2026
    26. Serum Granulysin Levels in Vitiligo and Alopecia Areata: A Potential Biomarker for Disease Activity and Dermoscopic Evaluation Journal of Clinical Medicine · 2025
    27. British Association of Dermatologists living guideline for managing people with alopecia areata 2024 British Journal of Dermatology · 2024 · 20 citations
    28. British Association of Dermatologists living guideline for managing people with alopecia areata 2025 British Journal of Dermatology · 2025
    29. Design and Characterization of Baricitinib Incorporated PLA 3D Printed Pills by Fused Deposition Modeling: An Oral Pill for Treating Alopecia Areata Polymers · 2023 · 2 citations
    30. Astilbin Activates the Reactive Oxidative Species/PPARγ Pathway to Suppress Effector CD4+ T Cell Activities via Direct Binding With Cytochrome P450 1B1 Frontiers in Pharmacology · 2022 · 1 citations